Details of Disease

General Information of Disease (ID: DISUZ4IS)

• Disease Name: Erythropoietic porphyrias
• Disease Class: 5C58: Inborn porphyrin/heme metabolism error
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DISUZ4IS: Erythropoietic porphyrias
• ICD Code:
  ICD-11: ICD-11: 5C58.12
  ICD-10: ICD-10: J00-J99

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 3 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Afamelanotide	DMVWHTG	Approved	Small molecular drug	[1]
Aripiprazole	DM3NUMH	Approved	Small molecular drug	[2]
Erythropoietin beta	DMQ32I7	Approved	NA	[2]

This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
MT-7117	DMHC8OS	Phase 2	NA	[3]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
• [2] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [3] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)